Latest California Healthline Stories
Warren and Klobuchar Say They Can Lower Drug Prices Without Congress’ Help
Democratic presidential candidates also returned to now-familiar themes in debating the differences between “Medicare for All” and more incremental reforms.
Sanders Targets Health Industry Profits. Are His Figures Right?
Calculations are complicated, but correct.
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Demócratas debaten si es “realista” un Medicare para Todos
Los siete candidatos que participaron del último debate de 2019 hablaron sobre la practicidad de una reforma radical de la atención médica, específicamente, de Medicare para Todos.
Yang And Sanders Use Maternal Mortality Stats To Talk About Race
These numbers are stark.
Warren’s Argument That Millions Can’t Afford Their Rx Drugs Holds Up
‘Medication insecurity’ is a thing.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
Did Joe Biden Overstate Democratic Voters’ Opposition To ‘Medicare For All’?
The term “vast” sets a high bar.
Do 160 Million Americans Really Like Their Health Plans? Kind Of
Former Vice President Joe Biden’s claim during the latest Democratic presidential debate relies on a squishy number, and context matters.
Surgeon General’s Marijuana Warning Omits Crucial Context
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.